Previous Article | Next Article ![]()
Antimicrobial Agents and Chemotherapy, April 2006, p. 1330-1335, Vol. 50, No. 4
0066-4804/06/$08.00+0 doi:10.1128/AAC.50.4.1330-1335.2006
Copyright © 2006, American Society for Microbiology. All Rights Reserved.
MICOER Institute, Munich, Germany,1 Johnson & Johnson Pharmaceutical Research and Development, Raritan, New Jersey2
Received 12 October 2005/ Returned for modification 8 December 2005/ Accepted 2 February 2006
Pandoraea spp. are gram-negative, glucose nonfermenting rods detectable in blood cultures and sputa of cystic fibrosis patients. They are resistant to various antibiotic groups, with imipenem being the only active ß-lactam. We isolated an imipenem-resistant (MIC, 64 µg/ml) Pandoraea pnomenusa strain from a cystic fibrosis patient. Cloning and sequencing identified two ß-lactamases of Bush group 2d, namely, the known OXA-33, located on an integron, and the novel carbapenem-hydrolyzing oxacillinase OXA-62. OXA-62 is only distantly related to other oxacillinases (OXA-50 being closest with 43% amino acid identity). It hydrolyzes penicillins, oxacillin, imipenem, and meropenem but not expanded-spectrum cephalosporins. The blaOXA-62 gene is chromosome located. No transposable elements were found in its genetic neighborhood. With OXA-62-specific primers, blaOXA-62 could be identified in all P. pnomenusa strains and appears to be species specific. This additional mechanism of carbapenem resistance further complicates the treatment of infections caused by P. pnomenusa.
This article has been cited by other articles:
| Clin. Vaccine Immunol. | Clin. Microbiol. Rev. |
|---|---|
| J. Clin. Microbiol. | ALL ASM JOURNALS |